Alexandra R. Grassian, Ph.D.
Affiliations: | 2011 | Harvard University, Cambridge, MA, United States |
Area:
Cell Biology, OncologyGoogle:
"Alexandra Grassian"Parents
Sign in to add mentor| Joan S. Brugge | grad student | 2011 | Harvard | |
| (Extracellular Matrix and Oncogene Regulation of Growth Factor Signaling and Cellular Metabolism.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Thomenius MJ, Totman J, Harvey D, et al. (2018) Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation. Plos One. 13: e0197372 |
| Chan-Penebre E, Armstrong K, Drew A, et al. (2017) Selective killing of SMARCA2- and SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type cells by inhibition of EZH2: In vitro and in vivo preclinical models. Molecular Cancer Therapeutics |
| Grassian AR, Harvey D, Fowler J, et al. (2017) Abstract 406: CRISPR pooled screening of hundreds of cancer cell lines identifies differential dependencies on epigenetic pathways and synthetic lethal relationships Cancer Research. 77: 406-406 |
| Kawano S, Grassian AR, Tsuda M, et al. (2016) Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma. Plos One. 11: e0158888 |
| Grassian AR, Scales TM, Knutson SK, et al. (2015) A Medium-Throughput Single Cell CRISPR-Cas9 Assay to Assess Gene Essentiality. Biological Procedures Online. 17: 15 |
| Grassian AR, Scales T, Knutson SK, et al. (2015) Abstract C162: A medium-throughput single cell CRISPR-Cas9 assay to assess gene essentiality Molecular Cancer Therapeutics. 14 |
| Grassian AR, Fowler J, Feldman I, et al. (2015) Abstract B78: CRISPR pooled screening identifies differential dependencies on epigenetic pathways Molecular Cancer Therapeutics. 14 |
| Grassian AR, Parker SJ, Davidson SM, et al. (2014) IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism. Cancer Research. 74: 3317-31 |
| Grassian AR, Pagliarini R, Chiang DY. (2014) Mutations of isocitrate dehydrogenase 1 and 2 in intrahepatic cholangiocarcinoma. Current Opinion in Gastroenterology. 30: 295-302 |
| Grassian AR, Parker S, Davidson S, et al. (2014) Abstract LB-139: IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism Cancer Research. 74 |